With Amazon's market value increasing by more than $400 billion in 2024, CBD Life Sciences is poised to generate new revenue growth with its best-selling CBD pain relief roll-ons and pet treats.
SCOTTSDALE, AZ / ACCESSWIRE / October 1, 2024 / CBD Life Sciences, Inc. (OTC PINK:CBDL), a fast-growing leader in the CBD industry, is pleased to announce its application to list on Amazon Marketplace. I am. Following a successful launch on Walmart Marketplace, this strategic expansion significantly expands the company's e-commerce footprint and brings its best-selling CBD pain cream roll-on and CBD pet treats to hundreds of customers worldwide. It promises to be available to millions of Amazon customers.
The move underscores CBD Life Sciences' commitment to rapidly expand its distribution network, as Amazon represents a major growth opportunity in the company's multichannel retail strategy.
Unlock new revenue potential through Amazon
With Amazon's vast customer base of over 300 million active users, CBDL is positioned to capture significant market share in the fast-growing CBD industry. Based on 1405.46% revenue growth since February 2024, the addition of Amazon to CBDL's retail arsenal creates new revenue streams and the company is expected to witness exponential growth in the near future .
“Our entry into the Amazon Marketplace is an important part of our aggressive expansion strategy,” said Lisa Nelson, president and CEO of CBD Life Sciences. We have already seen tremendous success with our product launches, and by leveraging Amazon's unparalleled reach, we expect to accelerate revenue growth and increase brand awareness across multiple demographics.”
Nelson said Amazon's platform has enabled high-demand products such as CBD pain cream roll-ons, which are popular with consumers looking for targeted, fast-acting pain relief, and CBD pet treats, which address common issues such as anxiety. He emphasized that the company offers unique advantages in expanding the market. Pet joint pain, etc. “This is a pivotal moment for CBDL as we position ourselves to dominate a new segment of the market with proven products that resonate with both human and pet health-conscious customers.”
Growth opportunities for investors
For investors, this expansion highlights a vital opportunity to invest in proven, fast-growing CBD companies. CBDL's aggressive entry into major retail platforms places it at the forefront of an industry expected to exceed $20 billion by 2025.
“The CBD market is poised for explosive growth, and CBDL is well-positioned to capitalize on this momentum,” Nelson said. “Our commitment to innovation and quality has resulted in significant revenue growth over the past year, and with Amazon's help, we are poised for even greater growth.”
CBD Life Sciences continues to pursue other lucrative partnerships with e-commerce giants and retail chains, further increasing the potential for solid returns for current and future investors. The launch of Amazon is expected to significantly increase sales and bring unparalleled brand awareness with millions of potential customers just a click away.
Join the Growth – Invest in CBD Life Sciences Inc.
With its expanding product portfolio, growing distribution channels, and strong leadership team, CBD Life Sciences Inc. offers an excellent opportunity for investors looking to enter the fast-growing CBD space. With the integration with Amazon, CBDL plans to increase both its revenue and market share, creating a great opportunity for investors to engage with a company aiming for sustained long-term growth.
About CBD Life Science Co., Ltd.
CBD Life Sciences Inc. (OTC: CBDL) is a recognized leader in the CBD industry, offering a range of top-quality CBD products designed to improve the health and well-being of humans and pets. The company's diverse product portfolio includes topicals, tinctures, edibles and pet care products. CBDL's relentless focus on innovation and customer satisfaction positions it for rapid growth in one of the fastest growing segments of the health and wellness industry.
Follow us on social media for updates!
X: https://www.x.com/CBDL_StockOTC
Instagram: https://www.instagram.com/cbd.vault
IR Contact: (email protected)
Forward-looking statements
Except for historical information contained herein, the matters discussed in this press release are forward-looking statements. Actual results may differ materially from those described in the forward-looking statements and are subject to risks and uncertainties. See CBD Life Sciences, Inc.'s OTC Markets filings. This may identify certain factors that could cause actual results or events to differ materially from those described in the forward-looking statements.
Safe Harbor Statement
This release contains forward-looking statements that are based on certain assumptions and reflect management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. These factors include general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will deliver expected benefits; Increasing competition. Availability and cost of capital. Ability to identify, develop and achieve commercial success. The level of expenditure required to maintain and improve the quality of service. Economic changes. changes in laws and regulations, including norms and standards, intellectual property rights, and taxation; or other unexpected matters. our ability to secure and maintain strategic relationships and distribution agreements; The Company disclaims any intention or obligation to update or revise any forward-looking statements to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking statements.
contact address
lisa nelson
CEO
(email protected)
4802091720
Source: CBD Life Sciences
